The role of monoallelic MUTYH variants is still under debate, and while some studies have indicated an increased cancer risk for carriers of a single MUTYH variant, the p.Gly396Asp variant alone is unlikely to be the explanation for the MSI-H and/or IHC status of the tumors in our patients [56, 57]. Here, MUTYH is linked to cancer.